Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $34.1200 (-3.94%) ($34.0200 - $34.1200) on Sun. Jun. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.76% (three month average) | RSI | 62 | Latest Price | $34.1200(-3.94%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO advances 2.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting HALO price | HALO will decline at least -1.38% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.38% (StdDev 2.76%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $35.16(-2.96%) | 10 Day Moving Average | $34.61(-1.42%) | 20 Day Moving Average | $34.01(0.32%) | To recent high | -11.8% | To recent low | 13.1% | Market Cap | $N/A | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |